SCHEMBL6084484

SCHEMBL6084484

COc1cccc(NC(=O)Nc2ccc(-c3n[nH]cc3-c3nc4ccccc4o3)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.57
MAPT P10636 5/20 0.57
KDM4E B2RXH2 4/20 0.57
ALDH1A1 P00352 4/20 0.57
HPGD P15428 4/20 0.57
KMT2A Q03164 4/20 0.57
GAA P10253 3/20 0.57
MEN1 O00255 3/20 0.57
POLB P06746 3/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TSHR P16473 5/20 0.54
USP2 O75604 3/20 0.54
STAT3 P40763 1/20 0.54
P2RY14 Q15391 3/20 0.54
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
MAPK1 P28482 1/20 0.52
KIT P10721 1/20 0.51
KDR P35968 1/20 0.51
HSPD1 P10809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086600 0.92 MAPT (0.56) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6084686 0.89 MAPT (0.54) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6086529 0.88 NPC1 (0.54) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6084412 0.88 MAPT (0.71) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6085104 0.88 AGPAT2 (0.51) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL6084830 0.87 AGPAT2 (0.53) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6084922 0.86 RAB9A (0.51) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6085606 0.86 MEN1 (0.55) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6087314 0.85 HPGD (0.54) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL6086034 0.85 NPC1 (0.52) HSD17B10MAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105535-B2 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2006-09-12 US claimed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP claimed
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2004-09-16 US claimed
US-7105535-B2 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2006-09-12 US disclosed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP disclosed
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors MAP3K15, MAP3K20, MAP3K3 HSD17B10 3948/4885MAPT 801/4885KDM4E 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.